Irinotecan decreases intestinal UDP-glucuronosyltransferase (UGT) 1A1 via TLR4/MyD88 pathway prior to the onset of diarrhea
Gabriel Tao, Fatima Dagher, Li Li, Rashim Singh, Ming Hu, Romi Ghose
Topics & Concepts
IrinotecanDiarrheaPharmacologyToxicityMetaboliteTLR2Active metaboliteLoperamideTLR4ProdrugMedicineChemistryInternal medicineInflammationColorectal cancerCancerCancer therapeutics and mechanismsNeutropenia and Cancer InfectionsLung Cancer Research Studies